Immunopathogenesis of idiopathic nephrotic syndrome

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 94-106

  Zhang, Shao Yu ^b   Audard, Vincent ^b   Fan, Qingfen ^b   Pawlak, Andre ^b   Lang, Philippe ^b   Sahali, Djillali ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LIPOID NEPHROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PODOCYTE; SIGNAL TRANSDUCTION;

CYTOKINES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNITY, INNATE; NEPHROSIS, LIPOID; PODOCYTES; SIGNAL TRANSDUCTION;

EID: 79551491756     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313947     Document Type: Article

References (94)

1. Niaudet P: Nephrotic syndrome in children. Curr Opin Pediatr 1993;5:174-179.
2. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S: Steroid responsiveness and frequency of relapse in adult- onset minimal change nephrotic syndrome. Am J Kidney Dis 2002;39:503-512.
3. Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P: Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology. Appl Pathol 1989;7:85-98.
4. Kestila M, Lenkkeri U, Mannikko M, et al: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephritic syndrome. Mol Cell 1998;1:575-582.
5. Boute N, Gribouval O, Roselli S, et al: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid- resistant nephritic syndrome. Nat Genet 2000;24:349-354.
6. Kaplan JM, Kim SH, North KN, et al: Mutations in ACTN4, encoding alpha- actinin- 4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251-256.
7. Reiser J, Polu KR, Moller CC, et al: TRPC6 is a glomerular slit diaphragm- associated channel required for normal renal function. Nat Genet 2005;37:739-744.
8. Benzing T: Signaling at the slit diaphragm. J Am Soc Nephrol 2004;15:1382-1391.
9. Daniel V, Trautmann Y, Konrad M, Nayir A, Scharer K: T- lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 1997;47:289-297.
10. Eddy AA, Symons JM: Nephrotic syndrome in childhood. Lancet 2003;362:629-639.
11. Niaudet P: Lipoid nephrosis in childhood. Rev Prat 2003;53:2027-2032.
12. Niaudet P, Gagnadoux MF, Broyer M: Treatment of childhood steroidresistant idiopathic nephrotic syndrome. Adv Nephrol Necker Hosp 1998;28:43-61.
13. Ramos EL: Recurrent diseases in the renal allograft. J Am Soc Nephrol 1991;2:109-121.
14. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF: Recurrence of idiopathic nephritic syndrome after renal transplantation. Lancet 1972;2:343-348.
15. Ali AA, Wilson E, Moorhead JF, et al. Minimal- change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 1994;58:849-852.
16. Rea R, Smith C, Sandhu K, Kwan J, Tomson C: Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:416-417.
17. Van Den Berg JG, Aten J, Chand MA, et al: Interleukin- 4 and interleukin- 13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 2000;11:413-422.
18. Feld SM, Figueroa P, Savin V, Nast CC, Sharma R, Sharma M, Hirschberg R, Adler SG: Plasmapheresis in the treatment of steroid- resistant focal segmental glomerulosclerosis innative kidneys. Am J Kidney Dis 1998;32:230-237.
19. Ginsburg DS, Dau P: Plasmapheresis in the treatment of steroid- resistant focal segmental glomerulosclerosis. Clin Nephrol 1997;48:282-287.
20. Savin VJ, Sharma R, Sharma M, et al: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-883.
21. Dantal J, Bigot E, Bogers W, et al: Effect of plasma protein adsorption on protein excretion in kidneytransplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330:7-14.
22. Dantal J, Godfrin Y, Koll R, et al: Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998;9:1709-1715.
23. Boulton Jones JM, Tulloch I, Dore B, McLay A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephritic patients. Clin Nephrol 1983;20:72-77.
24. Yoshizawa N, Kusumi Y, Matsumoto K, et al: Studies of a glomerular permeability factor in patients with minimal- change nephrotic syndrome. Nephron 1989;51:370-376.
25. Tanaka R, Yoshikawa N, Nakamura H, Ito H: Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 1992; 60:35-41.
26. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991;40:453-460.
27. Lagrue G, Branellec A, Blanc C, et al: A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine 1975;23: 73-75.
28. Shalhoub RJ: Pathogenesis of lipoid nephrosis: a disorder of T- cell function. Lancet 1974;2:556-560.
29. Fodor P, Saitua MT, Rodriguez E, Gonzalez B, Schlesinger L: T- cell dysfunction in minimal- change nephritic syndrome of childhood. Am J Dis Child 1982;136:713-717.
30. Peces R, Sanchez L, Gorostidi M, Alvarez J: Minimal change nephritic syndrome associated with Hodgkins lymphoma. Nephrol Dial Transplant 1991;6:155-158.
31. Orman SV, Schechter GP, Whang- Peng J, et al: Nephrotic syndrome associated with a clonal T- cell leukemia of large granular lymphocytes with cytotoxic function. Arch Intern Med 1986;146:1827-1829.
32. Karras A, de Montpreville V, Fakhouri F, Grunfeld JP, Lesavre P: Renal and thymic pathology in thymomaassociated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 2005;20: 1075-1082.
33. Neuhaus TJ, Shah V, Callard RE, Barratt TM: T- lymphocyte activation in steroid- sensitive nephritic syndrome in childhood. Nephrol Dial Transplant 1995;10:1348-1352.
34. Yan K, Nakahara K, Awa S, et al: The increase of memory T cell subsets in children with idiopathic nephritic syndrome. Nephron 1998;79:274-278.
35. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM: Control of T- cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001;182:58-67.
36. Frank C, Herrmann M, Fernandez S, et al: Dominant T cells in idiopathic nephrotic syndrome of childhood. Kidney Int 2000;57:510-517.
37. Sahali D, Pawlak A, Valanciute A, et al: A novel approach to investigation of the pathogenesis of active minimal- change nephritic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002;13:1238-1247.
38. Stefanovic V, Golubovic E, Mitic- Zlatkovic M, Vlahovic P, Jovanovic O, Bogdanovic R: Interleukin- 12 and interferon- gamma production in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 1998;12:463-466.
39. Kimata H, Fujimoto M, Furusho K: Involvement of interleukin (IL)- 13, but not IL- 4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 1995;25:1497-1501.
40. Valanciuté A, le Gouvello S, Solhonne B, et al: NF- kappa B p65 antagonizes IL- 4 induction by c- maf in minimal change nephrotic syndrome. J Immunol 2004;172:688-698.
41. Ho IC, Hodge MR, Rooney JW, Glimcher LH: The proto- oncogene c- maf is responsible for tissuespecific expression of interleukin- 4. Cell 1996;85:973-983.
42. Nurieva RI, Duong J, Kishikawa H, et al: Transcriptional regulation of th2 differentiation by inducible costimulator. Immunity 2003;18:801-811.
43. Chesi M, Bergsagel PL, Shonukan OO, et al: Frequent dysregulation of the c- maf proto- oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 1998;91: 4457-4463.
44. Kataoka K, Noda M, Nishizawa M: Maf nuclear oncoprotein recognizes sequences related to an AP- 1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol 1994;14:700-712.
45. Kim JI, Ho IC, Grusby MJ, Glimcher LH: The transcription factor c- Maf controls the production of interleukin- 4 but not other Th2 cytokines. Immunity 1999;10:745-751.
46. Karin M, Ben- Neriah Y: Phosphorylation meets ubiquitination: the control of NF- [kappa]B activity. Annu Rev Immunol 2000; 18:621-663.
47. Li Q, Verma IM: NF- kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-734.
48. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF- kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995;9:2723-2735.
49. Silverman N, Maniatis T: NF- kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001;15:2321-2342.
50. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF- kappa B. Annu Rev Cell Biol 1994;10:405-455.
51. Lain de Lera T, Folgueira L, Martin AG, et al: Expression of IkappaBalpha in the nucleus of human peripheral blood T lymphocytes. Oncogene 1999;18:1581-1588.
52. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr: Tumor necrosis factor and interleukin- 1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF- kappa B activation. Mol Cell Biol 1993;13:3301-3310.
53. Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi- Cherradi SE, Liou HC, et al: Critical roles of c- Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 2002;110:843-850.
54. Sahali D, Pawlak A, Le Gouvello S, et al: Transcriptional and posttranscriptional alterations of IkappaBalpha in active minimalchange nephrotic syndrome. J Am Soc Nephrol 2001;12:1648-1658.
55. Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J: Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994;24:799-805.
56. Casolaro V, Georas SN, Song Z, et al: Inhibition of NF- AT- dependent transcription by NF- kappa B: implications for differential gene expression in T helper cell subsets. Proc Natl Acad Sci USA 1995;92:11623-11627.
57. Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, et al: Preferential role for NF- kappa B/Rel signaling in the type 1 but not type 2 T cell- dependent immune response in vivo. J Immunol 1999;163:5116-5124.
58. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A: A critical role for NF- kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
59. Rudd CE, Schneider H: Unifying concepts in CD28, ICOS and CTLA4 coreceptor signalling. Nat Rev Immunol 2003;3:544-556.
60. Nurieva RI, Mai XM, Forbush K, Bevan MJ, Dong C: B7h is required for T cell activation, differentiation, and effector function. Proc Natl Acad Sci USA 2003;100:14163-14168.
61. Tafuri A, Shahinian A, Bladt F, et al: ICOS is essential for effective T- helper- cell responses. Nature 2001;409:105-109.
62. Lin CY, Chen CH, Lee PP: In vitro B- lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy. Pediatr Nephrol 1989;3:254-258.
63. Dong C, Nurieva RI: Regulation of immune and autoimmune responses by ICOS. J Autoimmun 2003;21:255-260.
64. Nagase T, Kikuno R, Hattori A, Kondo Y, Okumura K, Ohara O: Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 2000;7:347-355.
65. Grimbert P, Valanciute A, Audard V, et al: Truncation of C- mip (Tc- mip), a new proximal signaling protein, induces c- maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 2003;198:797-807.
66. Grimbert P, Valanciute A, Audard V, Lang P, Guellaen G, Sahali D: The Filamin- A is a partner of Tc- mip, a new adapter protein involved in c- maf- dependent Th2 signaling pathway. Mol Immunol 2004;40:1257-1261.
67. Medzhitov R: Toll- like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
68. Reiser J, von Gersdorff G, Loos M, et al: Induction of B7- 1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113:1390-1397.
69. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF- kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994;91:752-756.
70. Brattsand R, Linden M: Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10(Suppl 2):81- 90, discussion 91-92.
71. Meyer S, Kohler NG, Joly A: Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF- kappaB activation. FEBS Lett 1997;413:354-358. (Pubitemid 27353299)
72. Kerjaschki D: Caught flat- footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001;108:1583-1587.
73. Drenckhahn D, Franke RP: Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab Invest 1988;59:673-682.
74. Mundel P, Gilbert P, Kriz W: Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 1991;39:1047-1056.
75. Adler S: Characterization of glomerular epithelial cell matrix receptors. Am J Pathol 1992;141:571-578.
76. Regele HM, Fillipovic E, Langer B, et al: Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000;11:403-412.
77. Tryggvason K, Wartiovaara J: Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001;10:543-549.
78. Wernerson A, Duner F, Pettersson E, et al: Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003;18:70-76.
79. Hingorani SR, Finn LS, Kowalewska J, McDonald RA, Eddy AA: Expression of nephrin in acquired forms of nephritic syndrome in childhood. Pediatr Nephrol 2004;19:300-305.
80. Huber TB, Hartleben B, Kim J, et al: Nephrin and CD2AP associate with phosphoinositide 3- OH kinase and stimulate AKT- dependent signaling. Mol Cell Biol 2003;23:4917-4928.
81. Wolf G, Stahl RA: CD2- associated protein and glomerular disease. Lancet 2003;362:1746-1748.
82. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 2002;13:3005-3015.
83. Schachter AD, Strehlau J, Zurakowski D, et al: Increased nuclear factorkappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. Transplantation 2000;70: 1107-1110.
84. Saxena S, Mittal A, Andal A: Pattern of interleukins in minimal- change nephrotic syndrome of childhood. Nephron 1993;65:56-61.
85. Matsumoto K: Decreased production of interleukin- 1 by monocytes from patients with lipoid nephrosis. Clin Nephrol 1989;31:292-296.
86. Suranyi MG, Guasch A, Hall BM, Myers BD: Elevated levels of tumor necrosis factor- alpha in the nephritic syndrome in humans. Am J Kidney Dis 1993;21:251-259.
87. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM: Increased IL- 2, IL- 4 and interferon- gamma (IFN- gamma) in steroid- sensitive nephrotic syndrome. Clin Exp Immunol 1995;100:475-479.
88. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC: Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL- 13 mRNA expression in relapse. J Am Soc Nephrol 1999;10:529-537.
89. Hulton SA, Neuhaus TJ, Callard RE, Dillon MJ, Barratt TM: Circulating interleukin 2 receptor (IL2R) in nephritic syndrome. Kidney Int Suppl 1997;58:S83-S84.
90. Chen WP, Lin CY: Augmented expression of interleukin- 6 and interleukin- 1 genes in the mesangium of IgM mesangial nephropathy. Nephron 1994;68:10-19.
91. Garin EH, Blanchard DK, Matsushima K, Djeu JY: IL- 8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 1994;45:1311-1317.
92. Matsumoto K: Decreased release of IL- 10 by monocytes from patients with lipoid nephrosis. Clin Exp Immunol 1995;102:603-607.
93. Matsumoto K, Kanmatsuse K: Increased IL- 12 release by monocytes in nephrotic patients. Clin Exp Immunol 1999;117:361-367.
94. Zachwieja J, Bobkowski W, Dobrowolska- Zachwieja A, Lewandowska- Stachowiak M, Zaniew M, Maciejewski J: Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr Nephrol 2002;17:733-740. (Pubitemid 36097357)